Sort   by:  
 Page size 
UnknownOutcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Not available
S-EPMC8764730 | biostudies-literature
UnknownSafety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting.
Not available
S-EPMC12121429 | biostudies-literature
UnknownLive-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial.
Not available
S-EPMC12780950 | biostudies-literature
UnknownOutcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Not available
S-EPMC9115442 | biostudies-literature
UnknownSafety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
Not available
S-EPMC5849090 | biostudies-literature
UnknownPrevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Not available
S-EPMC5937161 | biostudies-literature
UnknownOptimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.
Not available
S-EPMC5620669 | biostudies-literature
UnknownMultidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines.
Not available
S-EPMC7547090 | biostudies-literature
Sort   by:  
 Page size